Inogen, Inc. (INGN) Guidance & Earnings Results

On 2026-08-06 Inogen, Inc. raised guidance: "FY2026 adjusted EBITDA ~$4.0M (from $2.7M in 2025); revenue…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

INGNInogen, Inc.Follow INGN — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 188.4M
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Raised	FY2026 adjusted EBITDA ~$4.0M (from $2.7M in 2025); revenue $355-361M · full year
7 May 26	Reaffirmed	Q2 2026 revenue $94M-$97M; FY2026 revenue $366M-$373M · full year
24 Feb 26	Raised	FY 2026 revenue $366M-$373M, ~6% growth at midpoint
5 Nov 25	Raised	Adjusted EBITDA guidance raised to ~$2M from prior; revenue guidance reiterated at $354M-$357M · full year
7 Aug 25	Raised	FY2025 revenue raised to $354-357M from prior; Q3 revenue $91-93M; adjusted EBITDA breakeven expected for FY2025 · full year

Inogen, Inc. — questions

What guidance did Inogen, Inc. give?: On 2026-08-06: "FY2026 adjusted EBITDA ~$4.0M (from $2.7M in 2025); revenue $355-361M"
When does Inogen, Inc. report earnings?: Inogen, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from Inogen, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.